The results suggest that myeloma cells with upregulated RUNX2 not only inhibit the proliferation and differentiation of osteoblasts but also promote the differentiation of osteoblasts to osteoclasts, which indirectly suppresses osteoclast activity. This evidence concerns the gene RUNX2 and plasma cell myeloma.